Pacific Biosciences Of California reported $-67969000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agilent A:US USD 471M 60M
Bruker BRKR:US USD 131.3M 57.4M
Danaher DHR:US USD 2.3B 281M
Fluidigm FLDM:US USD -29027000 9.54M
General Electric GE:US USD -72000000 268M
Illumina ILMN:US USD -3657000000 3.08B
Myriad Genetics MYGN:US USD -45000000 27.2M
Nanostring Technologies NSTG:US USD -34941000 2.15M
Perkinelmer PKI:US USD 110.78M 140.08M
Roche Holding ROG:VX 11.55B 3.47B
Thermo Fisher Scientific TMO:US USD 1.86B 151M
Waters WAT:US USD 192.01M 7.62M